Correlation between anti-Xa and occurrence of thrombosis and haemorrhage in post-surgical patients treated with either logiparin® (LMWH) or unfractionated heparin
- 1 March 1992
- journal article
- clinical trial
- Published by Elsevier in Thrombosis Research
- Vol. 65 (4-5), 641-650
- https://doi.org/10.1016/0049-3848(92)90213-t
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Prevention of perioperative deep vein thrombosis in general surgery: A multicentre double blind study comparing two doses of Logiparin and standard heparinBritish Journal of Surgery, 1991
- The Antithrombotic Activity and Pharmacokinetics of Enoxaparine, A Low Molecular Weight Heparin, In Humans Given Single Subcutaneous Doses of 20 to 80 mgThe Journal of Clinical Pharmacology, 1988
- Should Thromboprophylactic Dosage of Low Molecular Weight Heparin Be Adapted to Patient’s Weight?Thrombosis and Haemostasis, 1988
- The Mode of Action of Heparin in PlasmaThrombosis and Haemostasis, 1988
- Increased Anti-Xa Bioavailability for a Low Molecular Weight Heparin (PK 10169) Compared with Unfractionated HeparinSeminars in Thrombosis and Hemostasis, 1985
- The relative importance of thrombin inhibition and factor Xa inhibition to the antithrombotic effects of heparinBlood, 1985
- Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4Biochemical Journal, 1984